S&P 500 7,722.60 +0.60%
Nasdaq 26,477.81 +1.18%
S&P/TSX 36,171.49 +0.63%
Apple 347.10 +0.93%
Nvidia 217.94 +0.90%
Microsoft 531.33 −0.24%
Shopify 232.93 −1.27%
Royal Bank 285.46 +0.42%
CAD/USD 0.7111 −0.36%
CLOSED · 02:35 ET
Market ClerkRecap
Wed Oct 28 · markets closed3 signals on Oct 27171 insider buys this week · $184.9MCIRO short report next: Oct 30The week ahead

LYCA

Lycia Therapeutics, Inc.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
26.11
−2.74 −9.50%
USD · close Oct 27

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Insider trading

SEC FORM 4 · OPEN-MARKET ONLY
+$37.7M
Net, 90 days
6 / 0
Buys / sells, 90 days
1
Distinct buyers
$37.7M
Bought, 90 days
TradedFiledInsiderTypeSharesPriceValue
Oct 27Oct 27Venrock Healthcare Capital Partners III, L.P. · 10% ownerBuy31,067$26.84$834K
Oct 27Oct 27Venrock Healthcare Capital Partners III, L.P. · 10% ownerBuy8,729$25.84$226K
Oct 26Oct 27Venrock Healthcare Capital Partners III, L.P. · 10% ownerBuy8,261$26.97$223K
Oct 26Oct 27Venrock Healthcare Capital Partners III, L.P. · 10% ownerBuy1,944,444$18.00$35M
Oct 23Oct 27Venrock Healthcare Capital Partners III, L.P. · 10% ownerBuy28,379$26.11$741K
Oct 23Oct 27Venrock Healthcare Capital Partners III, L.P. · 10% ownerBuy24,560$25.68$631K

Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.

Watch LYCA. Know when insiders buy.
One email the day a filing lands. Free.